Sean Dodge
Stock Analyst at RBC Capital
(2.11)
# 2,706
Out of 4,757 analysts
132
Total ratings
31.96%
Success rate
-1.54%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $3.54 | -1.13% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $185.85 | +45.28% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $9.03 | +32.89% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $186.49 | +41.03% | 2 | Jan 15, 2025 | |
| HCAT Health Catalyst | Maintains: Sector Perform | $9 → $7 | $4.55 | +53.85% | 9 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $8.74 | +94.51% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $25.77 | +24.18% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $5.01 | +19.76% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $103.68 | +1.27% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $11.82 | +43.82% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $43.69 | -22.18% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $28.62 | -51.08% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.94 | +102.43% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.69 | +8.99% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $10.44 | +34.10% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $177.03 | -81.36% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.40 | +12,757.14% | 2 | Mar 9, 2022 |
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $3.54
Upside: -1.13%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $185.85
Upside: +45.28%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $9.03
Upside: +32.89%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $186.49
Upside: +41.03%
Health Catalyst
Jan 15, 2025
Maintains: Sector Perform
Price Target: $9 → $7
Current: $4.55
Upside: +53.85%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.74
Upside: +94.51%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $25.77
Upside: +24.18%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $5.01
Upside: +19.76%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $103.68
Upside: +1.27%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $11.82
Upside: +43.82%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $43.69
Upside: -22.18%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $28.62
Upside: -51.08%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.94
Upside: +102.43%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $25.69
Upside: +8.99%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $10.44
Upside: +34.10%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $177.03
Upside: -81.36%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.40
Upside: +12,757.14%